30 Mar 2010 07:00
For filings with the FSA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying Source BioScience plc issuer of existing shares to which voting
rights are attached: ii
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights Yes
An acquisition or disposal of qualifying financial instruments which No may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect No to qualifying financial instruments
An event changing the breakdown of voting rights No Other (please No specify):
3. Full name of person(s) subject to Gartmore Investment Limited the notification obligation: iii
4. Full name of shareholder(s) (if Gartmore Fledgling Trust plc different from 3.):iv
5. Date of the transaction and date 25 March 2010 on which the threshold is crossed or reached: v 6. Date on which issuer notified: 26 March 2010 7. Threshold(s) that is/are crossed 5% or reached: vi, vii 8. Notified details:A: Voting rights attached to shares viii, ixClass/type of Situation previous Resulting situation after shares to the triggering the triggering transaction transaction if possible Number Number Number Number of % of voting using of of of shares voting rights x the ISIN CODE Shares Voting rights Rights Direct Direct Indirect Direct Indirect xi xii GB0009739649 N/A N/A 12,325,000 12,325,000 6.049% B: Qualifying Financial Instruments Resulting situation after the triggering transaction
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date xiii Conversion Period rights that may be rights xiv acquired if the instrument is exercised/ converted.
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date xvii Conversion rights instrument rights xix, xx instrument period refers to xviii Nominal Delta Total (A+B+C) Number of voting rights Percentage of voting rights 12,325,000 6.049%
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: All figures are based on the Company's issued share capital of 203,765,232 as provided by Exshare 14. Contact name: RDU@Gartmore.com 15. Contact telephone number: 0207 782 2324 Note: Annex should only be submitted to the FSA not the issuer Annex: Notification of major interests in sharesxxii
A: Identity of the persons or legal entity subject to the notification obligation
Full name Gartmore Investment Limited (including legal form of legal entities) Contact address Gartmore House, 8 Fenchurch Place, (registered office for legal entities) London EC3M 4PB Phone number & email RDU@Gartmore.com 0207 782 2324 Other useful information (at least legal representative for legal persons)
B: Identity of the notifier, if applicable
Full name Contact address Phone number & email Other useful information(e.g. functional relationship with the person or legal entity subject to the notification obligation) C: Additional information
For notes on how to complete form TR-1 please see the FSA website.
vendor